Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction

作者: Iris E. Allijn , Bertrand M.S. Czarny , Xiaoyuan Wang , Suet Yen Chong , Marek Weiler

DOI: 10.1016/J.JCONREL.2016.12.042

关键词:

摘要: Inflammation is a known mediator of adverse ventricular remodeling after myocardial infarction (MI) that may lead to reduction ejection fraction and subsequent heart failure. Berberine isoquinoline quarternary alkaloid from plants has been associated with anti-inflammatory, anti-oxidative, cardioprotective properties. Its poor solubility in aqueous buffers its short half-life the circulation upon injection, however, have hampering extensive usage this natural product. We hypothesized encapsulation berberine into long circulating liposomes could improve therapeutic availability efficacy by protecting cardiac function against MI vivo. Berberine-loaded were prepared ethanol injection characterized. They contained 0.3 mg/mL drug 0.11 μm diameter. Subsequently they tested for IL-6 secretion inhibition RAW 264.7 macrophages protection C57BL/6J mice. In vitro, free significantly inhibited (IC50 = 10.4 μM), whereas encapsulated did not as it was released formulation time frame vitro study. vivo, berberine-loaded preserved at day 28 64% compared control berberine. conclusion, liposomal enhanced buffer preserves MI. This shows delivery improves identifies potential treatment

参考文章(26)
Zhouqing Huang, Zhihua Han, Bozhi Ye, Zhenyu Dai, Peiren Shan, Zhongqiu Lu, Kezhi Dai, Changqian Wang, Weijian Huang, Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. European Journal of Pharmacology. ,vol. 762, pp. 1- 10 ,(2015) , 10.1016/J.EJPHAR.2015.05.028
C. Allen, N. Dos Santos, R. Gallagher, G.N.C. Chiu, Y. Shu, W.M. Li, S.A. Johnstone, A.S. Janoff, L.D. Mayer, M.S. Webb, M.B. Bally, Controlling the Physical Behavior and Biological Performance of Liposome Formulations Through Use of Surface Grafted Poly(ethylene Glycol) Bioscience Reports. ,vol. 22, pp. 225- 250 ,(2002) , 10.1023/A:1020186505848
Mark E. Lobatto, Claudia Calcagno, Antoine Millon, Max L. Senders, Francois Fay, Philip M. Robson, Sarayu Ramachandran, Tina Binderup, Maarten P.M. Paridaans, Steven Sensarn, Stephan Rogalla, Ronald E. Gordon, Luis Cardoso, Gert Storm, Josbert M. Metselaar, Christopher H. Contag, Erik S. G. Stroes, Zahi A. Fayad, Willem J.M. Mulder, Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging ACS Nano. ,vol. 9, pp. 1837- 1847 ,(2015) , 10.1021/NN506750R
Gonçalo C. Pereira, Ana F. Branco, Júlio A. C. Matos, Sandro L. Pereira, Donna Parke, Edward L. Perkins, Teresa L. Serafim, Vilma A. Sardão, Maria S. Santos, Antonio J. M. Moreno, Jon Holy, Paulo J. Oliveira, Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. Journal of Pharmacology and Experimental Therapeutics. ,vol. 323, pp. 636- 649 ,(2007) , 10.1124/JPET.107.128017
Chi-Wai Lau, Xiao-Qiang Yao, Zhen-Yu Chen, Wing-Hung Ko, Yu Huang, Cardiovascular actions of berberine. Cardiovascular Drug Reviews. ,vol. 19, pp. 234- 244 ,(2006) , 10.1111/J.1527-3466.2001.TB00068.X
Benjamin J. Wrigley, Gregory Y.H. Lip, Eduard Shantsila, The role of monocytes and inflammation in the pathophysiology of heart failure. European Journal of Heart Failure. ,vol. 13, pp. 1161- 1171 ,(2011) , 10.1093/EURJHF/HFR122
Chiraz Jaafar-Maalej, Roudayna Diab, Véronique Andrieu, Abdelhamid Elaissari, Hatem Fessi, Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation Journal of Liposome Research. ,vol. 20, pp. 228- 243 ,(2010) , 10.3109/08982100903347923
Nikolaos G Frangogiannis, C Wayne Smith, Mark L Entman, The inflammatory response in myocardial infarction Cardiovascular Research. ,vol. 53, pp. 31- 47 ,(2002) , 10.1016/S0008-6363(01)00434-5